Bristol Bladder Trial

NCT01616875 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Infiltrating Bladder Urothelial Carcinoma

Interventions

DRUG: Cabazitaxel + Cisplatin chemotherapy

Sponsor

University Hospitals Bristol and Weston NHS Foundation Trust

Collaborators

[object Object]